GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 117 filers reported holding GENERATION BIO CO in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,534 | -47.1% | 14,125 | -40.0% | 0.00% | – |
| Q1 2023 | $101,222 | -67.6% | 23,540 | -50.6% | 0.00% | – |
| Q2 2022 | $312,000 | +72.4% | 47,628 | +92.7% | 0.00% | – |
| Q1 2022 | $181,000 | +98.9% | 24,715 | +93.1% | 0.00% | – |
| Q4 2021 | $91,000 | -59.7% | 12,800 | +52.4% | 0.00% | – |
| Q2 2021 | $226,000 | -34.5% | 8,400 | -30.6% | 0.00% | – |
| Q1 2021 | $345,000 | – | 12,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
| GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
| HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
| Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
| PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
| HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
| Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
| Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
| BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |